Re: Warrant Exercise Incentive Program
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 06:37AM
|
Re: Volume almost 100,000 at 11am
|
2
|
Resverlogix Corp.
|
Mar 13, 2019 01:06PM
|
Re: Volume almost 100,000 at 11am
|
2
|
Resverlogix Corp.
|
Mar 13, 2019 01:26PM
|
Re: Volume almost 100,000 at 11am
|
3
|
Resverlogix Corp.
|
Mar 13, 2019 02:50PM
|
Re: Volume almost 100,000 at 11am
|
2
|
Resverlogix Corp.
|
Mar 13, 2019 03:25PM
|
Re: Volume almost 100,000 at 11am
|
4
|
Resverlogix Corp.
|
Mar 13, 2019 11:08AM
|
Re: Video on BET inhibition in renal and cardiovascular disease
|
2
|
Resverlogix Corp.
|
Sep 24, 2019 12:42PM
|
Re: Vacepa new
|
3
|
Resverlogix Corp.
|
Mar 19, 2019 04:01PM
|
Re: Useful review on epigenetics and CKD for the scientists
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 09:38AM
|
Re: Useful review on epigenetics and CKD for the scientists
|
1
|
Resverlogix Corp.
|
Nov 25, 2019 10:35AM
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
5
|
Resverlogix Corp.
|
May 02, 2019 11:53PM
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
8
|
Resverlogix Corp.
|
May 03, 2019 06:23AM
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
5
|
Resverlogix Corp.
|
May 03, 2019 06:37AM
|
Re: Update
|
1
|
Resverlogix Corp.
|
Jun 12, 2019 09:40AM
|
Re: Upcoming CVOT results
|
2
|
Resverlogix Corp.
|
Apr 12, 2019 10:17AM
|
Re: Upcoming CVOT results
|
3
|
Resverlogix Corp.
|
Apr 12, 2019 11:14AM
|
Re: Upcoming CVOT results
|
1
|
Resverlogix Corp.
|
Apr 12, 2019 12:02PM
|
Re: Two Thoughts - 250 and 270
|
2
|
Resverlogix Corp.
|
Dec 14, 2018 05:26AM
|
Re: Tundup's message
|
3
|
Resverlogix Corp.
|
Apr 13, 2019 01:23PM
|
Re: Tundup's message
|
2
|
Resverlogix Corp.
|
Apr 14, 2019 07:02AM
|